1 active not recruiting, 1 not yet recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Rituximab (active comparator): new trials by email Literature Review of Rituximab (active comparator) trials Research Report on Rituximab (active comparator)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Iopofosine I 131 vs. R-CD in WM Patients Iopofosine I 131, Rituximab (active comparator), Cyclophosphamate - Waldenstrom Macroglobulinaemia, Waldenstrom Macroglobulinemia | Phase 3 | Not yet recruiting | Cellectar Biosciences, Inc. | 219 | 2026-12-01 | 2026-08-14 |
| Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis KYV101, Rituximab (active comparator) - Rheumatoid Arthritis | Phase 1 / Phase 2 | Active not recruiting | Charite University, Berlin, Germany | 13 | 2024-12-04 | 2026-03-05 |
Arthritis, Rheumatoid (1) · Waldenstrom Macroglobulinemia (1)
Cellectar Biosciences, Inc. (1) · Charite University, Berlin, Germany (1)
Germany (1)
David Simon, Professor Dr. med. (1)